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Abstract
Introduction and hypothesis Surgical management of uterine
prolapse varies greatly and recently uterus-preserving tech-
niques have been gaining popularity. The aim of this study
was to compare patient-reported outcomes after cervical am-
putation versus vaginal hysterectomy, with or without con-
comitant anterior colporrhaphy, in women suffering from pel-
vic organ prolapse.
Method We carried out a population-based longitudinal co-
hort study with data from the Swedish National Quality
Register for Gynecological Surgery. Between 2006 and
2013, a total of 3,174 patients with uterine prolapse were
identified, who had undergone primary surgery with either
cervical amputation or vaginal hysterectomy, with or without
concomitant anterior colporrhaphy. Pre- and postoperative
prolapse-related symptoms and patient satisfaction were
assessed, in addition to complications and adverse events.
Between-group comparisons were performed using univariate
and multivariate logistic regression.
Results There were no differences between the two groups in
neither symptom relief nor patient satisfaction. In both groups
a total of 81 % of the women reported the absence of vaginal
bulging 1 year after surgery and a total of 89 % were satisfied
with the result of the operation. The vaginal hysterectomy
group had a higher rate of severe complications than the
cervical amputation group, 1.9 % vs 0.2 % (p < 0.001). The
vaginal hysterectomy group also had a longer duration of sur-
gery and greater perioperative blood loss, in addition to longer
hospitalization.
Conclusions Cervical amputation seems to perform equally
well in comparison to vaginal hysterectomy in the treatment
of uterine prolapse, but with less morbidity and a lower rate of
severe complications.
Keywords Anterior colporrhaphy . Cervical amputation .
Pelvicorganprolapse .Recurrence .Uterineprolapse .Vaginal
hysterectomy
Introduction
Pelvic organ prolapse (POP) is a common condition amongst
the female population and the lifetime risk for prolapse or
incontinence surgery is 11 % by the age of 80 years, with a
29 % risk of reoperation [1]. Surgical management of uterine
prolapse varies greatly and there are currently insufficient data
to guide practice [2]. Vaginal hysterectomy, including some
kind of vaginal vault suspension, has traditionally been the
most common surgical procedure in the treatment of uterine
prolapse [1, 3], but uterus-preserving techniques are gaining
popularity [4, 5]. Recent studies have shown a desire from the
patients to retain the uterus in the case of equal outcome with
hysterectomy [6, 7]. Uterus-preserving techniques have been
shown to be associated with less morbidity and shorter hospi-
talization [8] and it has also been suggested that hysterectomy
causes damage to the vascular and nerve supply of the pelvis,
resulting in bladder dysfunction and recurrence of prolapse [9,
10]. Procedures such as abdominal sacrocolpopexy and
sacrospinous fixation have been evaluated in randomized tri-
als and have shown high success rates in comparison to
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vaginal hysterectomy [2, 11, 12]. Randomized trials evaluat-
ing techniques which include amputation of the cervix are
lacking. In some papers cervical amputation is even described
as an obsolete procedure [12]. However, based on the current
literature, procedures including amputation of the cervix ap-
pear to be equally as effective with regard to anatomical cure
and recurrence rates, but with less morbidity than vaginal
hysterectomy [8, 13–15].
The aim of the present study was to compare the outcomes
of cervical amputation versus vaginal hysterectomy, with or
without concomitant anterior vaginal wall repair, in women
suffering from uterine prolapse, using a population-based co-
hort selected from a national quality register.
Materials and methods
Data source
In this longitudinal cohort study data were collected from the
Swedish National Quality Register for Gynecological
Surgery. The register was established in 1997 and the majority
(44 out of 55) of Sweden’s gynecological departments partic-
ipate. Collection of data concerning POP surgery started in
2006. Data are collected prospectively using patient question-
naires and forms completed by the physicians. The physicians
report data on admission, surgery, and discharge, including
preoperative gynecological examination of the patient. The
preoperative patient questionnaires include questions
concerning demographic data and medical history in addition
to questions about symptoms associated with POP.
Postoperative questionnaires are filled in 8 weeks and 1 year
after surgery and include questions about POP symptoms,
complications, and patient satisfaction. The study design, in-
cluding the use of data from the register, was approved by the
Regional Board of Ethics in Stockholm, Sweden (Dnr
2014/958-31/4).
Study population
The patients included in the study were women with symp-
tomatic uterine prolapse stage I–IV, with or without anterior
vaginal wall prolapse stage I–IV, according to the validated
Pelvic Organ Prolapse Quantification System (POP-Q) [16],
who have undergone either cervical amputation or vaginal
hysterectomy, with or without concomitant anterior
colporrhaphy, between January 2006 and December 2013.
Exclusion criteria included previous prolapse or urinary in-
continence surgery, a uterus larger than 12 weeks’ gestation,
and concomitant posterior colporrhaphy or enterocele repair.
A total of 4,047 patients, meeting the criteria described above,
were identified in the register database.
Description of the procedures
In the case of concomitant anterior colporrhaphy, this proce-
dure is performed first. Anterior colporrhaphy involves a
transvaginal incision of the anterior vaginal wall, 2–3 cm pos-
terior to the external urethral meatus almost to the vaginal
vault or neck of the cervix, and dissection of the bladder from
the vagina. The pubocervical fascia is then adapted in the
midline, after which the vaginal epithelium is closed.
In cervical amputation, the cervix is circumcised and the
bladder is dissected from the cervical neck. The peritoneum is
not opened. After amputation of the cervix, the vaginal epi-
thelium and the cardinal ligaments are often sutured to the stump.
In vaginal hysterectomy the vaginal wall around the cervix
is circumcised. After bladder dissection, the anterior and pos-
terior peritoneum is opened. The uterus is released in several
steps using clamps and sutures or an electro-thermal bipolar
tissue sealing and dividing system. Vault suspension is often
performed by suturing the uterosacral or cardinal ligaments to
the vaginal vault. The mucosa is then closed.
Outcomes
Baseline data were collected both from forms completed by
the physician (age, functional status, and POP-Q) and from the
preoperative questionnaire completed by the patient (BMI,
parity, smoking, cesarean deliveries, use of estrogen replace-
ment therapy, and menopausal status). Functional outcome
measures were retrieved from the questionnaires completed
by the patients. The primary outcome was patient-reported
vaginal bulging at the 1 year follow-up questionnaire: BDo
you experience a feeling of bulging or protrusion in the vag-
inal area?^ The question was dichotomized from five answer
options (never or almost never into Bno^ and 1–3 times per
month, 1–3 times per week, and daily into Byes^). Secondary
outcomes included surgical complications and adverse events
related to the procedure reported by the physician, patient-
reported satisfaction, changes in urinary and bowel symptoms,
and sexual function 1 year after surgery. Questions about uri-
nary and bowel symptoms were recoded from five answer
options into three (never and almost never into Bnever,^ 1–3
times per month, 1–3 times per week into Bsometimes,^ and
daily into Bdaily^). Sexual activity was reported by answering
the question BHave you had coitus in the past 3 months?^Data
on complications were reported by the physician at the time of
surgery and up to 1 year postoperatively. The severe compli-
cations included severe intra-abdominal bleeding, severe
intra-abdominal infections or sepsis, ureteric injuries, bowel
injuries, myocardial infarction, and severe complications re-
lated to the anesthesia. The mild to moderate complications
consisted of bladder injuries, lower urinary tract infections or
other mild postoperative infections, obstipation, nausea, and
prolonged postoperative pain, vaginal bleeding, or fatigue.
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Statistical analysis
Baseline characteristics are presented as means ± SD or me-
dians and range for continuous variables and as frequencies
for categorical variables. For the comparison of baseline var-
iables between groups we used the Mann–Whitney U test
when analyzing continuous data and Fisher’s exact test for
categorical variables. Categorical endpoints were analyzed
using univariate and multivariate logistic regression, dichoto-
mized outcomes with binary regression and multiple answer
outcomes with the proportional odds model. Outcome mea-
sures were analyzed using logistic regression. The regression
model adjusted for the following variables: surgical method,
age, parity, body mass index (BMI), preoperative degree of
anterior and apical compartment prolapse (according to the
POP-Q), concomitant anterior colporrhaphy, symptoms at
baseline, and menopausal status. Results of the logistic regres-
sion analyses are presented as odds ratios with 95 % confi-
dence intervals. Comparison of outcomes within groups were
analyzed using the Wilcoxon signed rank and McNemar tests.
A p value of <0.05 was considered significant for all compar-
isons. Statistical analyses were performed using SPSS version
22 software (IBM, Armonk, NY, USA).
Results
Study population
Of the 4,047 patients eligible for the study, a total of 3,174
(78 %) women responded to the primary outcome question
(sensation of vaginal bulging) in the 1-year follow-up ques-
tionnaire. Of the 3,174 respondents, 1,195 patients (38 %)
were treated with vaginal hysterectomy and 1,979 patients
(62 %) with cervical amputation. There were no significant
differences in baseline characteristics between the groups, ex-
cept for menopausal status (Table 1). Concomitant anterior
colporrhaphy was performed in 1,013 patients in the hyster-
ectomy group (85 %) and in 1,757 patients in the cervical
amputation group (89 %; Table 1). The relative number of
cervical amputations in comparison to vaginal hysterectomies
was greater in stage I–II apical descent, whereas the relative
number of hysterectomies was higher in stage III–IV (Fig. 1).
Outcome measures
Table 2 describes the mechanical, urinary and bowel symp-
toms, and sexual activity before and 1 year after surgery with-
in the treatment groups. One year postoperatively, there was
significant relief from all urinary and bowel symptoms in both
treatment groups. Sexual activity also improved significantly
in both groups. Comparisons between vaginal hysterectomy
and cervical amputation 1 year after surgery are shown in
Table 3. There were no statistical differences between the
two groups neither in symptom relief nor in patient satisfac-
tion. In both groups a total of 81 % of the women with preop-
erative vaginal bulging were asymptomatic 1 year after sur-
gery and a total of 89 % were satisfied with the result of the
operation. The results persisted after multivariate logistic re-
gression analysis.
The presence of a vaginal bulging sensation 1 year postop-
eratively was considered to be symptomatic recurrence and an
analysis of the Bcured prolapse^ versus Brecurrent prolapse^
group was made to identify risk factors for recurrence. The
two groups differed in that the patients with a symptomatic
recurrence were somewhat younger (mean age ± SD; 61.5 ±
10.5 vs 63.4 ± 10.3, p = 0.001) and had a higher BMI (mean
BMI ± SD; 26.2 ± 4.3 vs 25.7 ± 3.8, p = 0.04) compared with
the patients with Bcured prolapse.^ There were no statistical
differences when comparing the two groups considering the
severity of prolapse in the apical or anterior compartment,
functional status (ASA classification), parity, or whether or
not concomitant anterior colporrhaphy was performed.
The primary outcome, the sensation of vaginal bulging
1 year postoperatively, was also evaluated in different sub-
groups (Table 4). Both techniques performed equally well in
every subgroup analysis. The only exception was the sub-
group without concomitant anterior colporrhaphy, in which
cervical amputation was superior to vaginal hysterectomy.
Adverse events
Adverse events are presented in Table 5. The rate of severe
complications was significantly higher in the hysterectomy
group than in the cervical amputation group, 23 out of 1,195
(1.9 %) vs 4 out of 1,979 (0.2 %), p < 0.001. The severe com-
plications in the hysterectomy group were: intra-abdominal
bleeding (n = 8), severe intra-abdominal infection or sepsis
(n = 7), ureteric injuries (n = 4), bowel injuries (n = 2), myo-
cardial infarction (n = 1), and severe complications related to
the anesthesia (n = 1). The severe complications in the cervical
amputation group consisted of: severe bleeding (n = 2) and
severe infection (n = 2). There was no difference in the rate
of mild to moderate complications between the groups, 146
out of 1,195 (12.2 %) in the vaginal hysterectomy group ver-
sus 246 out of 1,979 (12.4 %) in the cervical amputation
group, p = 0.9.
The hysterectomy group had a significantly longer mean
duration of surgery (76.2 vs 50.0 min, p < 0.001) and greater
mean amount of blood loss (100.1 vs 44.6ml, p < 0.001) com-
pared with the cervical amputation group. The hysterectomy
group also received prophylactic antibiotics and prophylaxis
against venous thrombosis to a greater extent, and they had a
longer hospitalization (1.7 vs 0.8 days, p < 0.001) and a longer
period until return to normal activities of daily living (6.1 vs
4.8 days, p < 0.001) than the cervical amputation group.
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Age at surgery (years) mean (±SD) 63.2 (±10.4) 63.1 (±10.5) 1.0
Body mass index (kg/m2) mean (±SD) 25.9 (±4.1) 25.8 (±3.8) 0.6
Parity median (range) 2 (0–10) 2 (0–10) 0.1
Cesarean sections median (range) 0 (0–3) 0 (0–3) 0.4
Current smoker, n (%)
Yes 118 (11) 158 (10) 0.3
No 960 (89) 1,461 (90)
Estrogen replacement therapy, n (%)
Yes 67 (6) 87 (5) 0.4
No 1,049 (94) 1,591 (95)
Postmenopausal, n (%)
Yes 800 (77) 1,284 (81) 0.03
No 236 (23) 307 (19)
ASA classification, n (%)
I 699 (58) 1,203 (61) 0.5
II 464 (39) 731 (37)
III 32 (3) 44 (2)
POP-Q stage apex, n (%)
I 44 (5) 134 (9)
II 381 (45) 776 (55) <0.001
III 338 (40) 459 (32)
IV 81 (10) 49 (4)
POP-Q stage anterior wall, n (%)
I 38 (5) 89 (6) <0.001
II 351 (43) 716 (52)
III 359 (44) 536 (39)
IV 75 (9) 47 (3)
Concomitant anterior colporrhaphy, n (%)
Yes 1,013 (85) 1,757 (89) 0.001
No 181 (15) 222 (11)
n = 134













Stage I Stage II Stage III Stage IV
VH group CA group
n = 44




Fig. 1 Number of vaginal
hysterectomies (VH) in relation to
cervical amputations (CA) at
different stages of uterine
prolapse
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Discussion
The results of this large, population-based register study indi-
cate that cervical amputation performs equally as well as vag-
inal hysterectomy in the treatment of women with uterine
prolapse. There was no difference in patient-reported symp-
tom relief and satisfaction 1 year after surgery, but the rate of
severe complications was significantly lower in the cervical
amputation group. The findings corroborate those of previous
studies comparing these two techniques [8, 13, 14]. In the
subgroup of patients where no concomitant anterior
colporrhaphy was performed, the cervical amputation group
had a significantly lower symptomatic recurrence rate 1 year
after surgery than the vaginal hysterectomy group, indicating
that cervical amputation may be superior to vaginal hysterec-
tomy in the treatment of apical descent.
In this study, cured prolapse was solely symptomatically
defined, as we did not have information about postoperative
POP-Q status. An absence of vaginal bulge symptoms strong-
ly correlates with patient-reported improvement and treatment
success [17]. Using the definition described above, treatment
success was similar (81 %) in each group. In a study by Thys





Preoperatively, n (%) Postoperatively, n (%) p value Preoperatively, n (%) Postoperatively, n (%) p value
Vaginal bulging
Yes 1,017 (94) 223 (19) <0.001 1,686 (96) 336 (19) <0.001
No 62 (6) 972 (81) 73 (4) 1,613 (81)
Satisfaction
Satisfied 1,028 (89) 1,714 (89)
Neither nor 90 (8) 134 (7)
Dissatisfied 37 (3) 69 (4)
Straining to void
Never 545 (51) 999 (86) <0.001 917 (53) 1,636 (85) <0.001
Sometimes 171 (16) 89 (8) 307 (18) 179 (9)
Daily 344 (33) 71 (6) 509 (29) 117 (6)
Urinary incontinence
Never 649 (60) 892 (76) <0.001 1,069 (61) 1,443 (74) <0.001
Sometimes 265 (25) 188 (16) 452 (26) 365 (19)
Daily 165 (15) 97 (8) 241 (14) 143 (7)
Urgency
Never 331 (29) 764 (66) <0.001 571 (33) 1,267 (67) <0.001
Sometimes 302 (28) 249 (22) 534 (31) 432 (23)
Daily 469 (43) 144 (12) 640 (38) 193 (10)
Nocturia
0–1 times per night 817 (74) 975 (82) <0.001 1,337 (75) 1,607 (81) <0.001
≥ 2 times per night 288 (26) 217 (18) 448 (25) 366 (19)
Straining to defecate
Never 744 (69) 927 (79) <0.001 1,230 (71) 1,504 (78) <0.001
Sometimes 246 (23) 203 (17) 408 (23) 345 (18)
Daily 83 (8) 44 (4) 107 (6) 75 (4)
Digitation
Never 861 (82) 1,035 (90) <0.001 1,436 (84) 1,728 (90) <0.001
Sometimes 131 (12) 95 (8) 200 (12) 147 (8)
Daily 63 (6) 28 (2) 72 (4) 34 (2)
Sexually active
No 632 (59) 577 (52) <0.001 1,042 (59) 986 (53) <0.001
Yes 448 (41) 534 (48) 715 (41) 879 (47)
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et al. comparing the Manchester Fothergill (MF) procedure
with vaginal hysterectomy (VH), the objective recurrence
rates were 18 % in the MF group and 19 % in the VH group
with a median follow-up time of 75 months and there were no
differences in POP-related symptoms postoperatively [13]. De
Boer et al. compared the modified Manchester procedure (cer-
vical amputation with uterosacral ligament plication) with
vaginal hysterectomy. Both procedures performed excellently
in the middle compartment [14]. In a review article from 2009
by Dietz et al., the anatomical cure rate in apical support
ranged between 93 and 100 % in the Manchester procedure
group.
In the present study, the preoperative degree of uterine pro-
lapse was more pronounced in the vaginal hysterectomy
group compared with the cervical amputation group
(Table 1). This may reflect a general conception that







OR (95 % CI)b, c p value
Postoperatively, n (%) Postoperatively, n (%)
Vaginal bulging
Yes 223 (19) 336 (19) 1.0 (0.7–1.3) 0.8
No 972 (81) 1,613 (81)
Satisfaction
Satisfied 1,028 (89) 1,714 (89) 1.1 (0.8–1.5) 0.6
Neither nor 90 (8) 134 (7)
Dissatisfied 37 (3) 69 (4)
Straining to void
Never 999 (86) 1,636 (85) 0.8 (0.6–1.1) 0.2
Sometimes 89 (8) 179 (9)
Daily 71 (6) 117 (6)
Urinary incontinence
Never 892 (76) 1,443 (74) 1.0 (0.8–1.3) 0.9
Sometimes 188 (16) 365 (19)
Daily 97 (8) 143 (7)
Urgency
Never 764 (66) 1,267 (67) 0.9 (0.8–1.2) 0.6
Sometimes 249 (22) 432 (23)
Daily 144 (12) 193 (10)
Nocturia
0–1 times per night 975 (82) 1,607 (81) 0.9 (0.6–1.2) 0.4
≥ 2 times per night 217 (18) 366 (19)
Straining to defecate
Never 927 (79) 1,504 (78) 1.1 (0.8–1.3) 1.0
Sometimes 203 (17) 345 (18)
Daily 44 (4) 75 (4)
Digitation
Never 1,035 (90) 1,728 (90) 1.1 (0.9–1.5) 0.3
Sometimes 95 (8) 147 (8)
Daily 28 (2) 34 (2)
Sexually active
No 577 (52) 986 (53) 1.0 (0.8–1.4) 0.8
Yes 534 (48) 879 (47)
a Reference
bModulated toward negative values
c Adjusted for age, parity, body mass index (BMI), degree of anterior and apical compartment prolapse, concom-
itant anterior colporrhaphy, symptoms at baseline, and menopausal status
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suspension of the vaginal cuff is needed for proper repair of
advanced apical prolapse. However, similar treatment results
persisted after a multivariate regression analysis adjusting for
preoperative POP-Q stage, among other variables. When
comparing the results of vaginal hysterectomy with cervical
amputation in each subgroup of preoperative POP-Q stage,
there were no significant differences. Hence, cervical ampu-
tation with ligament attachment can also be considered in
advanced uterine prolapse.
Uterine prolapse is often associated with co-existing pro-
lapse in the anterior vaginal wall [18], which is reflected in this
study, where the vast majority of patients had concomitant
anterior vaginal wall repair. This study cannot answer the
question: does the presence of prolapse symptoms postopera-
tively represent a failure in the apical or the anterior compart-
ment? In both groups, significant improvement was seen in all
self-reported bladder dysfunction symptoms, as expected after
an anterior colporrhaphy [19, 20]. It was notable, however,
that self-reported symptoms of obstructive defecation also be-
came significantly less frequent, indicating that symptoms of
uterovaginal prolapse do not necessarily correlate with
compartment-specific defects [21].
Increasing age and excess weight are established risk fac-
tors for pelvic organ prolapse [1]. In the present study, women
with a lower BMI had less symptomatic recurrence than the
group with higher BMI. However, symptomatic recurrence
correlated inversely with age and the preoperative grade of
prolapse did not affect the risk of recurrence. One could spec-
ulate that younger women might be more physically active
and thus performing Bheavy activities^ postoperatively to a
greater extent, which increases the risk of recurrence.
Various surgical methods have been developed to improve
the outcome after surgery for apical prolapse. Sacrocolpopexy
and sacrospinous fixation can be performed not only in the
Table 4 Primary outcome
measure (vaginal bulging) 1 year
after surgery
Sub groups VH groupa CA group OR
(95%CI)b
p




All patients stage I n = 44 n = 134 0.7 (0.2–1.9) 0.5
No 35 (79) 100 (75)
Yes 9 (21) 34 (25)
All patients stage II n = 381 n = 776 1.0 (0.7–1.5) 0.9
No 306 (80) 636 (82)
Yes 75 (20) 140 (18)
All patients stage III n = 338 n = 459 1.1 (0.7–1.6) 0.8
No 281 (83) 380 (83)
Yes 57 (17) 79 (17)
All patients stage IV n = 81 n = 49 0.9 (0.3–2.7) 0.8
No 66 (81) 38 (78)
Yes 15 (19) 11 (22)
All stages with concomitant AC n = 1,013 n = 1,757 0.9 (0.6–1.1) 0.3
No 837 (83) 1,425 (81)
Yes 176 (17) 332 (19)
Stages II–III with concomitant AC n = 595 n = 1,080 0.9 (0.7–1.2) 0.5
No 494 (83) 884 (82)
Yes 101 (17) 196 (18)
All stages with no concomitant AC n = 181 n = 222 2.1 (1.1–4.3) 0.04
No 134 (74) 188 (85)
Yes 47 (26) 34 (15)
Stages II–III with no concomitant
AC
n = 123 n = 155 2.5 (1.1–5.9) 0.04
No 92 (75) 132 (85)
Yes 31 (25) 23 (15)
AC anterior colporrhaphy
a Reference
bAdjusted for surgical method, age, parity, body mass index (BMI), degree of anterior and apical compartment
prolapse (when appropriate), concomitant anterior colporrhaphy (when appropriate), symptoms at baseline, and
menopausal status
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treatment of vaginal vault prolapse, but also as uterus-sparing
techniques. Open abdominal sacrocolpopexy is the most suc-
cessful method in the surgical treatment of apical prolapse
regarding recurrence rates, but the procedure is associated
with an increased length of hospital stay, analgesic require-
ments, and costs compared with transvaginal procedures [2,
22]. Laparoscopic and robot-assisted sacrocolpopexies also
provide excellent short- to medium-term reconstructive out-
comes for patients with POP, but involve a shorter recovery
time than with open procedures [23]. These techniques,
though, can only partly replace the traditional ones, as they
require both high-technology operating facilities and experi-
enced surgeons. Their cost-effectiveness is currently unclear
[23]. The use of mesh in prolapse surgery has reduced recur-
rence rates and has therefore been used more frequently over
the last decade. However, the benefits must be weighed
against the disadvantages, such as mesh erosion (5–10 %)
and dyspareunia [24–26]. Sacrospinous hysteropexy is anoth-
er uterus-preserving technique that is aimed at fixing the uter-
us to the sacrospinous ligament—most commonly to the right
side to prevent lesions of the rectum. A newly published ran-
domized trial by Detollenaere et al. showed equal outcomes of
sacrospinous hysteropexy compared with vaginal hysterecto-
my [11].
Strengths of this study include prospective data collection
and a large study population treated in a routine medical care
setting. The operating clinics vary from large-scale teaching
hospitals to smaller private practitioners and the geographical
distribution of the patients is wide, which also increases the
external validity. The overall response rate of 78 % must be
considered an acceptable figure in a questionnaire-based study
and the possibility of response bias is relatively low [27].
The lack of objective measures postoperatively is a limita-
tion of our study, as this could have provided relevant infor-
mation about prolapse symptoms in relation to anatomical
outcome after uterine prolapse surgery. However, the aim of
POP surgery is symptom relief regardless of postoperative
anatomy. The register data provide no information about the
position of the isthmus and cervical length. Therefore, it is not
possible to evaluate the influence of possible cervix elonga-
tion on the choice of surgical method. The literature contains
no clear definition of cervical elongation. Some authors sug-
gest a definition including the corpus uteri/cervix ratio (CCR)
of < 1.5 [28, 29]. Using that definition, Mothes et al. found that
cervical elongation was present in 97.6 % of patients undergo-
ing hysterectomy due to objective and symptomatic uterine
POP stage II–IV, which would suggest that a considerable
amount of the patients in the present study might have had
some degree of cervical elongation [28]. Suspension of the
vaginal apex or cervical end is a standard procedure in vaginal
hysterectomy and cervical amputation, but the methods vary.
The database does not contain information regarding whether
a suspension of the cuff/stump was performed and details of
the suspension techniques are not registered. It is, in our opin-
ion, highly important to perform some kind of cuff suspension
to restore apical support, as it is not the hysterectomy alone
that corrects the prolapse.
The follow-up time of 1 year allows us to evaluate only
short-term outcomes. One long-term disadvantage of cervical
amputation is the possibility of cervical stenosis and thus







Mild and moderate 146 (12.2) 246 (12.4) 0.95
Severe 23 (1.9) 4 (0.2) <0.001
Operation time (min) mean (±SD) 76.2 (±30.8) 50.0 (±21.2) <0.001
Blood loss (ml) mean (±SD) 100.1 (±113.2) 44.6 (±64.5) <0.001
Days at hospital mean (±SD) 1.7 (0.9) 0.8 (0.8) <0.001
Days to normal ADL mean (±SD) 6.1 (±6.6) 4.8 (±6.3) <0.001
Antibiotic prophylaxis, n (%)
Yes 1,156 (97) 301 (15) <0.001
No 39 (3) 1677 (85)
Prophylaxis of venous thrombosis, n (%)
Yes 1,040 (92) 866 (51) <0.001
No 88 (8) 821 (49)
Anesthesia, n (%)
Intubation 597 (53) 620 (33) <0.001
Other 538 (47) 1,268 (67)
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complications such as hematometra and difficulties in diag-
nosing endometrial pathological conditions using histological
samples. These complications are not possible to evaluate in
the present study.
Another limitation of this study is that the patient question-
naires used in the register database are not validated POP
questionnaires. However, the primary outcome question re-
garding vaginal bulging sensation has been validated.
In conclusion, this study shows no difference between cer-
vical amputation and vaginal hysterectomy in symptomatic
outcomes or patient satisfaction in the treatment of uterine
prolapse 1 year after surgery. Cervical amputation is a less
invasive procedure with a short operation time, reduced blood
loss, low complication rates, and fast postoperative recovery
time compared with vaginal hysterectomy. The use of prophy-
lactic antibiotics and low molecular weight heparin can also
be reduced when performing a cervical amputation rather than
a vaginal hysterectomy. Based on these outcomes, we suggest
that cervical amputation is a reliable option with few compli-
cations in the treatment of women with uterine prolapse, when
no other indication for removal of the uterus exists.
Randomized controlled trials with long-term follow-up are
still needed to evaluate a comparison of cervical amputation
not only with vaginal hysterectomy, but also with other
uterine-preserving procedures.
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